Literature DB >> 15284429

Contrast-enhanced MR imaging of the heart: overview of the literature.

Robert R Edelman1.   

Abstract

The use of magnetic resonance (MR) imaging for cardiac diagnosis is expanding, aided by the administration of paramagnetic contrast agents for a growing number of clinical applications. This overview of the literature considers the principles and applications of cardiac MR imaging with an emphasis on the use of contrast media. Clinical applications of contrast material-enhanced MR imaging include the detection and characterization of intracardiac masses, thrombi, myocarditis, and sarcoidosis. Suspected myocardial ischemia and infarction, respectively, are diagnosed by using dynamic first-pass and delayed contrast enhancement. Promising new developments include blood pool contrast media, labeling of myocardial precursor cells, and contrast-enhanced imaging at very high fields. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284429     DOI: 10.1148/radiol.2323031558

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

Review 1.  [Molecular and parametric imaging with iron oxides].

Authors:  L Matuszewski; B Tombach; W Heindel; C Bremer
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

2.  Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis.

Authors:  B Borchert; T Lawrenz; M Bartelsmeier; S Röthemeyer; H Kuhn; C Stellbrink
Journal:  Clin Res Cardiol       Date:  2007-08-21       Impact factor: 5.460

3.  A study of in vitro and in vivo MR of free-breathing whole-heart 3D coronary angiography using parallel imaging.

Authors:  Hang Jin; Meng-Su Zeng; Mei-Ying Ge; Shan Yang; Cai-Zhong Chen; Ji-Zhang Shen; Ren-Chen Li
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-15       Impact factor: 2.357

4.  Quantitation of infarct size in patients with chronic coronary artery disease using rest-redistribution Tl-201 myocardial perfusion SPECT: correlation with contrast-enhanced cardiac magnetic resonance.

Authors:  David S Fieno; Louise E J Thomson; Piotr Slomka; Aiden Abidov; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

5.  Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.

Authors:  Paola Maria Cannaò; Luisa Altabella; Marcello Petrini; Marco Alì; Francesco Secchi; Francesco Sardanelli
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

6.  Late myocardial enhancement assessed by 64-MSCT in reperfused porcine myocardial infarction: diagnostic accuracy of low-dose CT protocols in comparison with magnetic resonance imaging.

Authors:  H Brodoefel; B Klumpp; A Reimann; M Ohmer; M Fenchel; S Schroeder; S Miller; C Claussen; A F Kopp; A M Scheule
Journal:  Eur Radiol       Date:  2006-06-27       Impact factor: 5.315

7.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

8.  Therapy for pediatric myocarditis.

Authors:  Charles E Canter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

9.  Initial results of cardiac imaging at 7 Tesla.

Authors:  C J Snyder; L DelaBarre; G J Metzger; P-F van de Moortele; C Akgun; K Ugurbil; J T Vaughan
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

10.  Cardiac magnetic resonance imaging: diagnostic value and utility in the follow-up of patients with acute myocarditis mimicking myocardial infarction.

Authors:  M Danti; S Sbarbati; N Alsadi; A Di Filippo; G Gangitano; L Giglio; V Salvini; M Amoruso; G S Camastra; G Ansalone; S Della Sala
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.